0.5266
-0.1674
(-24.12%)
At close: December 2 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-26,632.0000
-32,164.0000
-36,704.0000
-26,589.0000
-17,495.0000
Investing Cash Flow
24,874.0000
651.0000
-26,498.0000
--
--
Financing Cash Flow
-88.0000
1,068.0000
9,579.0000
617.0000
114,181.0000
End Cash Position
13,079.0000
6,697.0000
37,142.0000
90,765.0000
116,737.0000
Issuance of Capital Stock
--
1,224.0000
9,582.0000
--
113,876.0000
Issuance of Debt
--
--
--
--
301.0000
Repurchase of Capital Stock
-88.0000
-156.0000
-3.0000
--
--
Free Cash Flow
-26,632.0000
-32,164.0000
-36,704.0000
-26,589.0000
-17,495.0000
12/31/2020 - 2/3/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
PDSB PDS Biotechnology Corporation
1.6400
-1.20%
IKNA Ikena Oncology, Inc.
1.4800
-0.67%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
IBO Impact BioMedical Inc.
1.7499
-5.62%
VCNX Vaccinex, Inc.
1.2500
-3.10%
MBX MBX Biosciences, Inc.
10.01
-14.00%
APTO Aptose Biosciences Inc.
0.1760
+4.08%
KPTI Karyopharm Therapeutics Inc.
0.6221
-6.32%
GNFT.PA Genfit S.A.
3.5750
-2.85%